Bionic arm breakthrough? new implant aims for natural control

NCT ID NCT07325708

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 2 times

Summary

This early study tests a new implantable sensor array, called Phantom X, that picks up muscle signals to control a bionic arm. Ten adults with below-elbow amputations will receive the implant and be followed for up to 21 weeks. The goal is to see if the device is safe and allows more natural, intuitive hand and wrist movements.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Phantom X implantable EMG sensor array
What this could lead to
If successful, this could enable more natural and intuitive control of bionic arms for people with upper-limb amputations.
What could go wrong
This is a very early, first-in-human study with only 10 participants. The device may not work as expected, and there are risks from surgery and the implant itself.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 10 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patient has a unilateral upper-limb difference (congenital or acquired) at the transradial or wrist level. 2. The patient currently uses a myoelectric prosthesis or is deemed a suitable candidate for fitting with a myoelectric prosthesis. 3. Patient is a suitable candidate for the implantation of the Phantom X sensor array as assessed by the implanting physician. 4. Patient is at least 18 years old and can provide written informed consent. 5. Patient is willing to comply with study protocol and make required study visits. 6. Patient received amputation ≥ 12 months prior to consent. Exclusion Criteria: 1. Patient has a significant cognitive deficit resulting in inability to follow study directions. 2. Patient has a neuro-muscular deficit and is unable to initiate substantial muscle contraction in the residual limb as determined by the implanting physician or investigator. 3. Patient has another medical condition, which, in the opinion of the Investigator, may cause him/her to be non-compliant with the protocol, confound the data interpretation, or is associated with a life expectancy insufficient to allow for the completion of study procedures and follow-up. 4. The patient has a planned medical procedure (e.g., surgery) during the study period that could interfere with compliance with study visits or assessments. 5. Patient has an allergy to anesthesia or other medication used for sedation in the study. 6. Patient has an active implantable device (e.g. cardiac pacemaker, neuromodulation device) that can potentially interfere with the performance of Phantom X system. 7. Patient may require an MRI during the study duration. 8. Implantation of the device poses a health risk to the patient as determined by the implanting physician. 9. Women who are breastfeeding, currently pregnant or planning to become pregnant during the duration of the study or have a positive urine pregnancy test at screening.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Transradial amputation are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Cabrini Health Ltd

    RECRUITING

    Malvern, Victoria, 3189, Australia

  • ProMotion Prosthetics Pty Ltd

    RECRUITING

    Moorabbin, Victoria, 3189, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.